Logo Image
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardClinical Forum InsightsInsightsMedcastPeers & PerspectivesShorts
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement
Opinion|Videos|September 19, 2024

COBRA AND PROPELLER: Background and Results of Prior PSMA Imaging Trials

Author(s)Michael Gorin, MD

Michael Gorin, MD provides the background and results of two key imaging trials that reviewed the efficacy of this new copper-based agent.

Advertisement

Episodes in this series

EP. 1 PSMA PET Imaging: The Landscape and Current Challenges
EP. 1 PSMA PET Imaging: The Landscape and Current Challenges
EP. 2 Emerging Copper-Based Developments in PSMA Imaging
EP. 2 Emerging Copper-Based Developments in PSMA Imaging
EP. 3 COBRA AND PROPELLER: Background and Results of Prior PSMA Imaging Trials
Now Playing
EP. 3 COBRA AND PROPELLER: Background and Results of Prior PSMA Imaging Trials
EP. 4 The CLARIFY Trial Design and Objectives for PSMA Imaging
EP. 4 The CLARIFY Trial Design and Objectives for PSMA Imaging
EP. 5 Potential Impact of Forthcoming CLARIFY Trial Results
EP. 5 Potential Impact of Forthcoming CLARIFY Trial Results
Advertisement
Enhanced Detection in Prostate Cancer: The Promise of 64Cu-SAR-bisPSMA for Improved Imaging and Recurrence Reduction

Latest CME

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies
Multimedia

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

View more
Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis
Video

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

View more
Advertisement
Advertisement

Trending on Urology Times

1

AI-generated profiles impersonate female urologists to market ED products online

2

The role of diet and lifestyle in prostate cancer care, with Lorelei A. Mucci, ScD, MPH

3

Doublet or triplet? Urologists weighs in on mCSPC options

4

John Sfakianos, MD, discusses evolving management of recurrent LG-IR-NMIBC

5

Alternative BCG strains may help address ongoing supply challenges in NMIBC

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us